New drug tested to slow Parkinson's progression
Disease control
Recruiting now
This study is testing an investigational drug called TB006 in people with early-stage Parkinson's disease. The main goals are to see if TB006 is safe and if it can improve movement symptoms like tremors and stiffness. About 62 participants will be randomly assigned to receive eit…
Phase: PHASE2 • Sponsor: TrueBinding, Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC